AbbVie Inc. (NYSE:ABBV)

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

Stocks traded lower on Tuesday, and the 2018 midterm elections are finally here. Last week's stock market bounce was handily off of the lows, but investors have seen lower upside ...
Read Full Story »

AbbVie Little Changed Despite Big Bottom-Line Beat

AbbVie Inc. (NYSE: ABBV) released its third-quarter financial results before the markets opened on Friday. The pharma giant said it posted $2.14 in earnings per share (EPS) and $8.24 billion ...
Read Full Story »

Encana, Hanesbrands Sink into Thursday’s 52-Week Low Club

November 1, 2018: Here are four stocks trading with heavy volume among 84 equities making new 52-week lows by mid-day on Thursday. On the NYSE advancers lead decliners by about ...
Read Full Story »

Major Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

After over nine years of a rising stock market, we could be getting close to the end of the run. That does not ensure a bear market, and to be ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Rising Interest Rates and All, 13 Blue Chips Outyield 10-Year and 30-Year Treasuries

After a series of stops and starts throughout the Federal Reserve's interest rate hiking cycle, the eventual rise in long-term interest rates finally has started to play out in 2018. ...
Read Full Story »

Short Sellers Grow More Selective on Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Should AbbVie Be More Concerned About Its California Case for Humira?

AbbVie Inc. (NYSE: ABBV) shares took a dip on Wednesday after it was announced that the pharmaceutical giant would be facing a lawsuit from the California Department of Insurance in ...
Read Full Story »